A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in JapanMotoyoshi Yano, Kei Ogata, Yoshimasa Kobayashi et al.|Journal of Gastroenterology|2004Cited by 63
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1Michio Sata, Teruko Hino-Arinaga, Tatsuya Ide et al.|Journal of Gastroenterology|2011Cited by 42
An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitisAkiko Hisamochi, Takuji Torimura, Masayoshi Kage et al.|Journal of Gastroenterology|2015Cited by 38
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al.|Cancers|2021Cited by 32
Risk of malignancies in autoimmune hepatitis type 1 patients with a long‐term follow‐up in JapanTeruko Arinaga‐Hino, Tatsuya Ide, Ichiro Miyajima et al.|Hepatology Research|2017Cited by 16